678 Novel Nanoparticles and Nanostructured Materials for Pharmaceuticals and Medical Applications I


Description:
Nanoparticles and nanostructured materials have started to find applications in the food, biomedical and pharmaceutical sectors, typically either as carrier vehicle, as active ingredient or as diagnostic agent. Reports on the synthesis of such nanostructured particles, their characterization and/or performance are the focus of this session. Of special interest are strategies to control functionality during synthesis or post (surface-) modification of the nanostructured particles. Discussions on the toxicological aspects of their application are most welcome but not mandatory. Focus areas include, but are not limited to: -Synthesis & applications of novel organic and inorganic nanomaterials for Bio, Food and Pharma -Nanoscale materials and devices for biomedical applications -Biosensing & Bioimaging -Nano-nutraceuticals -Nanoparticle interfaces and (bio)functionalization -Nanoscale lipid assemblies for active ingredient delivery -Modeling & simulation of nanocarriers

Sponsor:
Nanoparticles
Co-Sponsor(s):
Pharmaceutical Discovery, Development and Manufacturing Forum (26), Pharmaceuticals (15B)


Chair:
Georgios A. Sotiriou
Assistant Professor
Karolinska Institutet
Department of Microbiology, Tumor and Cell Biology
Stockholm
Email: georgios.sotiriou@ki.se

Co-Chair:
Timothy Brenza
Assistant Professor
South Dakota School of Mines & Technology
Chemical and Biological Engineering
Rapid City, SD
Phone Number: 605-394-1766
Email: Timothy.Brenza@sdsmt.edu


Papers:
678a
Engineering the Surfaces of Fluorescently-Labeled Polymeric Nanoparticles for Drug Delivery
Ami Jo, Macromolecules Innovation Institute; Rui Zhang, Virginia Tech; Judy Riffle, Virginia Tech; Richey M. Davis, Virginia Tech
678b
Optimizing the Surface Property-Activity Relationship of Nanoscale Hydrogel Drug Delivery Systems
Angela Wagner, The University of Texas at Austin; Alex Shearer, The University of Texas at Austin; Alexandria Lawrence, The University of Texas at Austin; Bhaargavi Ashok, The University of Texas at Austin; Nicholas A. Peppas, University of Texas at Austin
678c
Paramagnetic Cations-Loaded Polydopamine Nanoparticles Cytotoxicity
Milena Vega, University of Salamanca; Celia Nieto, University of Salamanca; Gema Marcelo, University of Salamanca; Miguel A. Galán, University of Salamanca; Eva Martín del Valle, University of Salamanca
678d
Two-Photon Microscopy for Deep-Tissue Imaging of Dopaminergic Neuromodulation in the Brain
Jackson Travis Del Bonis-O'Donnell, University of California Berkeley; Ian McFarlane, University of California Berkeley; Ralph Page, University of California Berkeley; Abraham Beyene, University of California Berkeley; Eric Tindall, University of California Berkeley; Markita Landry, Chan Zuckerberg Biohub
678e
Ultrafast Post-Formulation Core Radiolabeling of Biodegradable Nanoparticles for PET Contrast Agents
Leon Z. Wang, Princeton University; Tristan L. Lim, Princeton University; Prashanth Padakanti, University of Pennsylvania; Hoang D. Lu, Princeton University; Abass Alavi, Hospital of the University of Pennsylvania, Perelman School of Medicine; Robert Mach, University of Pennsylvania; Robert K. Prud'homme, Princeton University
678f
Voltage-Sensitive Ultrasound Enhancing Agent: In Vitro and In Vivo analysis
Michael Cimorelli, Drexel University; Benjamin Andrien, Drexel University; Kyle Barrett, Drexel University; Aaron T. Fafarman, Drexel University; Andrew Kohut, University of Pennsylvania; Brett Angel, Drexel University; Steven P. Wrenn, Drexel University
Abstract Submissions Closed
See more of this Group/Topical: Particle Technology Forum
<< Previous Session | Next Session >>